Platelet transfusions more than double the risk of death among people with thrombotic thrombocytopenic purpura (TTP), according to a review of published studies.
Thrombotic thrombocytopenic purpura
Thrombotic thrombocytopenic purpura is a rare, life-threatening blood disorder marked by dangerous clotting and low platelet counts. Prompt diagnosis and treatment are critical, and with proper care, most people recover and avoid serious complications.
While there’s no cure for immune thrombocytopenia, a range of treatments — from steroids to platelet-boosting therapies — can help manage symptoms. Choosing the right plan depends on platelet levels, bleeding risk, and individual health considerations.
Latest news
There appears to be no link between high blood pressure in the first two days after an acute episode of thrombotic thrombocytopenic purpura (TTP)…